WO1993003138A1 - A method for over-expressing nucleic acids using an enhancer sequence from potato virus x - Google Patents

A method for over-expressing nucleic acids using an enhancer sequence from potato virus x Download PDF

Info

Publication number
WO1993003138A1
WO1993003138A1 PCT/US1992/005403 US9205403W WO9303138A1 WO 1993003138 A1 WO1993003138 A1 WO 1993003138A1 US 9205403 W US9205403 W US 9205403W WO 9303138 A1 WO9303138 A1 WO 9303138A1
Authority
WO
WIPO (PCT)
Prior art keywords
sequence
nucleic acid
cell
potato virus
phagemid
Prior art date
Application number
PCT/US1992/005403
Other languages
French (fr)
Inventor
Joseph G. Atabekov
Sergei Yu Morozov
Original Assignee
Scientific Dimensions Usa, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scientific Dimensions Usa, Inc. filed Critical Scientific Dimensions Usa, Inc.
Publication of WO1993003138A1 publication Critical patent/WO1993003138A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/40011Tymoviridae
    • C12N2770/40022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Definitions

  • the present invention relates to the use of cis- acting nucleic acid seguences to enhance the translation of isolated nucleic acid fragments. It also relates to the development of transgenic plants and cells that express the products of foreign DNA seguences in detectable, biologically effective concentrations.
  • transgenic plants have been an especially fertile system in which to conduct these studies.
  • the tissues of many plant species have been genetically and phenotypically transformed by the introduction of exogenous genes.
  • genetically altered tissues or cells may be induced to develop into transgenic plants which can transmit the introduced traits to their progeny through normal Mendelian inheritance.
  • the potential commercial utility of transgenic plants is enormous. Instead of slowly and painstakingly breeding plants over several generations to develop strains that possess certain desirable features (e.g. size, timing of crop, size of crop, resistance to plant diseases, etc.), with the advent of methods for producing transgenic plants it is possible to produce such strains in just one generation simply by inserting the genes that encode these traits.
  • A. tumefaciens harbors a tumor-inducing plasmid. Acrrobacterium introduces this plasmid into the genome of the infected plant host. The genetically altered host cells become tumorous and produce plant metabolites called opines on which the A ⁇ robacteriu has the unique ability to feed.
  • the natural pathogenic properties of A_j_ tumefaciens can be exploited to introduce foreign genes into plant tissues.
  • transgenic cells and plants involve the direct introduction of nucleic acids into the cytoplasm of plant cells.
  • Microinjection is one of the more popular methods for introducing foreign DNA sequences into a subject cell.
  • electroporation in which cells (usually protoplasts) are exposed to an electric shock that disrupts the cellular membranes and causes the transient formation of pores through which diffusible substances of appropriate size can penetrate into the cell.
  • Plant protoplasts that are subjected to electroporation can incorporate nucleic acid constructs from the surrounding medium.
  • nucleic acid constructs derived principally from plasmids and viruses that possess a variety of properties, such as the ability to direct the production of proteins and nucleic acids that result in replication and expression, that enable them to replicate in cells and express encoded proteins
  • vectors nucleic acid constructs derived principally from plasmids and viruses that possess a variety of properties, such as the ability to direct the production of proteins and nucleic acids that result in replication and expression, that enable them to replicate in cells and express encoded proteins
  • the exogenous nucleic acids may be incorporated into the genome of the plant and expressed in the same way as the plant's intrinsic genes, generation after generation. Some times the exogenous nucleic acids are not incorporated into the host cell genome. While for some applications non-incorporation might be desirable, for the purpose of producing a cell line that permanently expresses the transgene from generation to generation it is far preferable that the transgene be inserted into the host genome.
  • the foreign genes exert their effects primarily through their gene products, it is important that they be expressed at biologically effective levels (i.e., the gene products of the introduced sequence must be produced in detectable quantities and/or they must have a measurable phenotypic effect) .
  • biologically effective levels i.e., the gene products of the introduced sequence must be produced in detectable quantities and/or they must have a measurable phenotypic effect.
  • nucleic acid seguences that regulate the rates of transcription and translation have been identified.
  • the 5' untranslated leaders of various plant and animal viral mRNAs have been shown to enhance the translation of foreign eukaryotic and prokaryotic genes, both in vivo and in vitro .
  • Gallie D.R. et al . (1987) Nucleic Acids Res. 15, 8693-8711; Jobling S.A. and Gehrke L. (1987) Nature 325, 622-625; Dolph P.D., et al . (1988) J. Virol. 62, 2059-2066; Ruiz-Linares A., et al . (1989) Nucleic Acids Res.
  • Commonly used plant cell transcription promoters include the nopaline synthase promoter from the T-DNA of A ⁇ robacterium tumefaciens and the 35S promoter from the cauliflower mosaic virus.
  • PVX potato virus X
  • selected nucleic acids can be inserted in the vicinity of the efficient ⁇ ?-leader translational enhancer, or of a fragment having enhancer functions;
  • the phagemid can be used for the in vitro synthesis of mRNA transcripts of isolated genes attached to the 5 • '-proximal translational enhancer sequence;
  • selected genes or cDNAs that have been spliced downstream from the translational enhancer sequence can be excised together with the enhancer and this chimeric construct can easily be inserted into vectors that contain eukaryotic transcription signals in order to obtain high-level gene expression in transgenic plants or animals;
  • the ⁇ 3-seguence can be used as a specific tag for monitoring the transcription level of newly introduced genes in the cases when the transgenic cells are constructed to amplify authentic host genes.
  • the present invention provides an improved method for the enhanced expression of selected gene products, wherein selected nucleic acids are ligated to the PVX mRNA a ⁇ enhancer fragments or to fragments thereof having enhancer function, forming constructs which may be either translated in vitro in cell-free systems, or used to produce transgenic cells, animals and plants that express the gene product.
  • the present invention also provides a phagemid (pXK3 ⁇ ,9) , constructed by inserting the a ⁇ sequence derived from PVX mRNA into the phagemid pTZ18R (Pharmacia) , that can be maintained in Escherichia coli as a double-stranded plasmid, or isolated as single- stranded phage, or used to selectively synthesize RNA transcripts for hybridization probes, in vitro translation, protoplast electroporation and cell micro- injection.
  • a phagemid pXK3 ⁇ ,9
  • This pXK3 ⁇ / 3 is a versatile cloning and expression vector that allows nucleic acid sequences such as genes or cDNAs that are inserted downstream from the ⁇ ,9-leader to be sequenced and/or mutated, or excised as a cassette that contains the ⁇ sequence together with the gene or cDNA in preparation for microinjection, and/or inserted into plant- and animal-specific vectors.
  • This invention further provides additional phagemids derived from the PXK3 ⁇ ,*3.
  • One of them (pKX3 ) contains the a region of the a ⁇ seguence, the other one (pKX3,9) the ⁇ region. It also provides a variety of subfragments derived from the a ⁇ sequence that possess enhancer functions.
  • This invention also provides a method and a product for producing transgenic cells and transgenic plants.
  • NPTI neomycin phosphotransferase I
  • ⁇ -NPTI 10 ⁇ g/ml, 20 ⁇ g/ml, 40 ⁇ g/ml
  • RNA added (lane 8) .
  • ⁇ -NPTI 40 ⁇ g/ml, 20 ⁇ g/ml (lanes 1, 2) ; No enhancer-NPTI: 40 ⁇ g/ml (lane 3); ⁇ 3-NPTI: 40 ⁇ g/ml, 20 ⁇ g/ml (lanes 4, 5).
  • No enhancer-NPT-1 80 ⁇ g/ml, 120 ⁇ g/ml (lanes 1, 2): ⁇ 3-NPT-l: 80 ⁇ g/ml, 120 ⁇ g/ml (lanes 3,4); no RNA added (lane 5) 8
  • Fig. 3. (Published) Nucleotide sequences of the 5'- untranslated leaders of NPT II gene transcripts.
  • Fig. 4. (Published) SDS-PAGE of [ 35 S]-labelled translation products (rabbit reticulocyte lysate) of synthetic RNA transcripts of NPT II gene. Lane 1, control NPT II transcript; lane 3, a ⁇ -containing transcript; lane 3, no RNA added. Concentration of transcripts was 20 ⁇ g/ml.
  • Fig. 5. (Published) Nucleotide seguences of the 5'- untranslated leaders of Bacillus thuringiensis toxic protein gene transcripts. Fig. 6.
  • Lanes 1 and 2 control transcript (46 nt leader) (20 and 40 ⁇ g/ml, respectively) .
  • Lanes 3 and 4 control transcript (12 nt leader) (20 and 40 ⁇ g/ml, respectively) .
  • Fig. 9. The DNA sequences of the polylinker regions of pXK3 ⁇ and pXK3J phagemids (A) and nucleotide sequences of the leader regions of the corresponding in vitro RNA transcripts.
  • Fig. 11 Schematic map of phagemid pXK3Q. / 3. The numbers correspond to the parental plasmid pTZ18R.
  • Fig. 12 Nucleotide sequence of the region of pXK3 ⁇ 3 that contains the T7 promoter, the ⁇ 3-leader and the polylinker.
  • RNA transcripts wherein different subfragments of the a ⁇ region were spliced to the NPT1 gene.
  • PVX genomic RNA The 5' leader of potato virus X (PVX) genomic RNA (the 83 nucleotide sequence adjacent to the cap structure) has been shown to consist of two distinct sub-sequences, the ⁇ -sequence (41 nucleotides 3' to the cap that lack G) and the ⁇ -sequence (42 nucleotides upstream from the first AUG) .
  • Fig. 1 from Smirnyagina et al .
  • the ⁇ sequence enhanced the expression of several reporter genes that were inserted 3' to the ⁇ seguence and translated in cell free systems.
  • the ⁇ sequence enhanced the translation of a neomycin phosphotransferase I (NPT1) gene in cell-free systems from rabbit reticulocytes (RRL) , wheat germ (WG) and Krebs-2 ascites cell extracts (KA) by 6 to 40-fold (Fig. 2, taken from Smirnyagina et al . , (1991) Biochimie 73: 587-598).
  • the PVX ⁇ sequence was about as effective as the TMV ⁇ sequence in enhancing the expression of a reporter gene. (Fig.
  • NPTII neomycin phosphotransferase II
  • Figs. 5 and 6 Bacillus thuringiensis insect central protein
  • GUS Figs. 7 and 8
  • the Bglll- and BamHl-cut restriction fragment was excised from the pNEO plasmid (Pharmacia-LNB) and spliced into the BamHl cloning site of a phagemid which is also a subject of this invention, pXK3 ⁇ ,5, whose construction is described below.
  • the 5' leader of the transcript of the resulting plasmid includes a relatively long spacer (38 nucleotides in length) located between the AUG initiation codon and the 5'-terminal a ⁇ sequence (Fig. 3) .
  • the reporter gene was inserted into the same sites of the pTZl ⁇ R polylinker.
  • the plasmids were transcribed without m 7 GpppG, and the resulting transcripts were translated in the rabbit reticulocyte lysate.
  • the ⁇ sub-region by itself can enhance the translation of reporter genes to a level comparable with that achieved using the ⁇ seguence (Figs. 9 and 10) .
  • a DNA fragment that contained the entire ⁇ sequence and 8 base pairs of the ⁇ sequence was excised from pXK3 ⁇ 3 by co-digestion with EcoRI and Muni. The fragment was purified by gel electrophoresis and then fused to an EcoRI-cut pTZ18R. The blue colonies that were obtained after transformation of E. coli strain XL-IB were screened by hybridization and sequence analysis.
  • the DNA sequence corresponding to ⁇ -sequence and the polylinker in resulting PXK3 ⁇ phagemid are presented in Fig.
  • TMV-CP tobacco mosaic coat protein
  • TMV-CP The expression of the TMV-CP gene in rabbit reticulocyte lysates was found to be enhanced significantly by the a ⁇ seguence as well as by the ⁇ sequence alone. No enhancement was observed when the TMV-CP was coupled to the ⁇ seguence (Fig. 10) .
  • phagemid expression vector pXK3 ⁇ 3, Figs. 11 and 12
  • pXK3 ⁇ 3, Figs. 11 and 12 a versatile phagemid expression vector that allows selected nucleic acid fragments to be inserted downstream from the a ⁇ sequence, sequenced, transcribed in vitro or in vivo, mutated at will and/or excised as a cassette (together with the a ⁇ seguence) for insertion into plant- and animal-specific vectors.
  • the phagemid was constructed as follows: A double- stranded DNA corresponding to the a ⁇ sequence was chemically synthesized and fused to an EcoRI- and S al- cut pTZ18R phagemid (Pharmacia-LKB) . The resulting pXK3 ⁇ /3 contained the a ⁇ sequence flanked by an EcoRI site at its 5' border and multiple cloning sites at its 3' border (Figs. 11 and 12) . It also retained all the properties of the parental vector: pKX3 ⁇ 3 can be maintained in E.
  • coli as double-stranded plasmid, or it can be isolated as single-stranded phage following infection of XL-IB or NM522 cultures with the M13K07 helper phage (Pharmacia-LKB) .
  • the phagemid also contains the viral T7 promoter (Fig. 12) which can be used to selectively synthesize RNA transcripts for hybridization probes.
  • pK 3a ⁇ can be used for in vitro translation, protoplast electroporation and cell micro- injection.
  • the ⁇ sequence is also efficient as a translational enhancer in vivo (in protoplasts) and can be used for super-production of proteins in transgenic plants and probably in yeast cells and transgenic animals.
  • MOLECULE TYPE RNA (genomic)
  • HYPOTHETICAL NO
  • ANTI-SENSE NO
  • ORIGINAL SOURCE A) ORGANISM: Potato Virus X
  • MOLECULE TYPE mRNA
  • HYPOTHETICAL NO
  • ANTI-SENSE NO
  • ORIGINAL SOURCE A) ORGANISM: Potato Virus X
  • ORGANISM Bacillus thuringiensis
  • SEQUENCE DESCRIPTION SEQ ID NO:5: GGGAAUUCGA AAACUAAACC AUACACCAAC AACACAACCA AACCCACCAC GCCCAAUUGU 60
  • MOLECULE TYPE mRNA
  • HYPOTHETICAL NO
  • ANTI-SENSE NO
  • MOLECULE TYPE CDNA to mRNA
  • HYPOTHETICAL NO
  • ANTI-SENSE NO
  • SEQUENCE DESCRIPTION SEQ ID NO:9: AATTCGAAAA CTAAACCATA CACCAACAAC ACAACCAAAC CCACCACGCC CAATTCGAGC 60
  • MOLECULE TYPE mRNA
  • HYPOTHETICAL NO
  • ANTI-SENSE NO
  • ORIGINAL SOURCE (A) ORGANISM: tabacco mosaic virus
  • ORGANISM Potato Virus X
  • SEQUENCE DESCRIPTION SEQ ID NO:15: TAATACGACT CACTATAGGG AATTCGAAAA CTAAACCATA CACCACAACA CAACCAAACC 60

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

A method is described for efficiently expressing the products of selected nucleic acid sequences in cell-free systems, in cells, or in transgenic plants. The method is comprised of inserting the selected nucleic acids downstream from the αβ sequence derived from potato virus X (PVX) or from subfragments of the αβ sequence that retain enhancer function, and then introducing the hybrid construct into the genome of a cell or a plant. A phagemid (pKX3αβ) was constructed in which the αβ sequence was inserted 5' to several cloning sites into which the selected nucleic acid can be inserted. This phagemid can be maintained in Escherichia coli as a double-stranded plasmid; or it can be isolated as single-stranded phage, or it can be used to selectively synthesize RNA transcripts for hybridization probes, in vitro translation, protoplast electroporation and cell micro-injection.

Description

AMETHODFOROVER-EXPRESSINGNUCLEICACIDSUSINGANENHANCERSEQUENCEFROMPOTATOVIRUS
FIELD OP THE INVENTION
The present invention relates to the use of cis- acting nucleic acid seguences to enhance the translation of isolated nucleic acid fragments. It also relates to the development of transgenic plants and cells that express the products of foreign DNA seguences in detectable, biologically effective concentrations.
BACKGROUND OF THE INVENTION
The explosive progress in recombinant technigues have made it possible to obtain biologically important proteins in sufficient guantities for performing pioneering clinical studies, for developing new therapies, and for commercial exploitation. They have also led to the production of transgenic prokaryotic and eukaryotic animals and plants that express foreign genes and exhibit traits encoded by those genes. These transgenic organisms have been the subject of a host of studies and discoveries relating to normal physiological mechanisms and pathological states. They have also been instrumental in the development of effective treatments for different diseased states.
For many reasons, plants have been an especially fertile system in which to conduct these studies. The tissues of many plant species have been genetically and phenotypically transformed by the introduction of exogenous genes. In some plant species, genetically altered tissues or cells may be induced to develop into transgenic plants which can transmit the introduced traits to their progeny through normal Mendelian inheritance. The potential commercial utility of transgenic plants is enormous. Instead of slowly and painstakingly breeding plants over several generations to develop strains that possess certain desirable features (e.g. size, timing of crop, size of crop, resistance to plant diseases, etc.), with the advent of methods for producing transgenic plants it is possible to produce such strains in just one generation simply by inserting the genes that encode these traits.
There are several technigu.es for producing transgenic cells and plants. One method involves exploiting the unique properties of the plant pathogen Acrrobacterium tumefaciens. Natural (or wild-type) A. tumefaciens harbors a tumor-inducing plasmid. Acrrobacterium introduces this plasmid into the genome of the infected plant host. The genetically altered host cells become tumorous and produce plant metabolites called opines on which the Aσrobacteriu has the unique ability to feed. By removing the genes responsible for tumor induction and opine production and replacing them with selected exogenous chimeric genes, the natural pathogenic properties of A_j_ tumefaciens can be exploited to introduce foreign genes into plant tissues.
Other techniques for producing transgenic cells and plants involve the direct introduction of nucleic acids into the cytoplasm of plant cells. Microinjection is one of the more popular methods for introducing foreign DNA sequences into a subject cell. Another technique is electroporation, in which cells (usually protoplasts) are exposed to an electric shock that disrupts the cellular membranes and causes the transient formation of pores through which diffusible substances of appropriate size can penetrate into the cell. Plant protoplasts that are subjected to electroporation can incorporate nucleic acid constructs from the surrounding medium. Finally, a variety of vectors (nucleic acid constructs derived principally from plasmids and viruses that possess a variety of properties, such as the ability to direct the production of proteins and nucleic acids that result in replication and expression, that enable them to replicate in cells and express encoded proteins) have been developed that have greatly facilitated the expression of• recombinant nucleic acids and proteins.
Once introduced, the exogenous nucleic acids (The term nucleic acid is meant to encompass both RNA and DNA sequences, since it is currently a routine matter to generate a DNA sequence using the RNA as a template, and vice versa.) may be incorporated into the genome of the plant and expressed in the same way as the plant's intrinsic genes, generation after generation. Some times the exogenous nucleic acids are not incorporated into the host cell genome. While for some applications non-incorporation might be desirable, for the purpose of producing a cell line that permanently expresses the transgene from generation to generation it is far preferable that the transgene be inserted into the host genome.
Since the foreign genes exert their effects primarily through their gene products, it is important that they be expressed at biologically effective levels (i.e., the gene products of the introduced sequence must be produced in detectable quantities and/or they must have a measurable phenotypic effect) . To this end, many scientists have focused on optimizing the transcription and translation of foreign cDNA seguences that are introduced into plants.
Many nucleic acid seguences that regulate the rates of transcription and translation have been identified. For example, the 5' untranslated leaders of various plant and animal viral mRNAs have been shown to enhance the translation of foreign eukaryotic and prokaryotic genes, both in vivo and in vitro . Gallie D.R. , et al . (1987) Nucleic Acids Res. 15, 8693-8711; Jobling S.A. and Gehrke L. (1987) Nature 325, 622-625; Dolph P.D., et al . (1988) J. Virol. 62, 2059-2066; Ruiz-Linares A., et al . (1989) Nucleic Acids Res. 17, 2463-2476; Carrington J. C. and Freed D. D. (1990) J. Virol. 64, 1590-1597. Commonly used plant cell transcription promoters include the nopaline synthase promoter from the T-DNA of Aσrobacterium tumefaciens and the 35S promoter from the cauliflower mosaic virus.
Although these promoters are effective in any plant cells, the level of transcription varies considerably. The degree of enhancement depends on many factors, such as the number of the insertion events, the location of the insertion site or sites the genome of the transformed cell, the absence or presence of cis-or trans-acting regulatory factors. No one enhancer is equally effective in all circumstances. Therefore, a considerable amount of effort has been expended to identify new enhancers, to chart their properties and optimize their effects.
The traditional protocols for identifying, amplifying, sequencing and packaging DNA fragments used to produce transgenic organisms were time consuming. Each step often required that the DNA fragments be excised and inserted into a particular environment (e.g., plasmids were used for cloning and amplifying, and viral particles were used for sequencing) . The use of phagemids (recombinant nucleic acid constructs that are capable of being passaged and amplified in bacteria and also of being packaged into viral particles) , of which PTZ18R (Pharmacia-LKB) is an example, has greatly reduced the effort for certain applications. We have recently demonstrated that a region called the aβ seguence derived from potato virus X (PVX) is an efficient enhancer of gene expression in cell free systems. Smirnyagina et al . (1991), Biochimie 73: 587- 598) . Our invention involves the use of this sequence and its homologues to enhance the expression of exogenous nucleic acids in cell free systems and in transgenic cells and plants.
OBJECTS AND SUMMARY OF THE INVENTION
For the reasons mentioned above, it is an object of this invention to utilize subfragments of the PVX αβ seguence to provide improved new methods and nucleic acid constructs for the efficient expression of selected nucleic acids in cell free systems, in cells, and in transgenic plants.
It is a further object of this invention to provide a vector and a method for reducing the number of steps required for producing transgenic cells and plants, which include forming ah appropriate construct, sequencing the construct; performing site specific mutations; efficiently transforming cells; efficiently expressing the selected gene or DNA, and generating clones to maintain, and from which to harvest, the chimeric construct.
It is another object of this invention to provide a phagemid having the following properties:
(i) selected nucleic acids can be inserted in the vicinity of the efficient α?-leader translational enhancer, or of a fragment having enhancer functions;
(ii) the phagemid can be used for the in vitro synthesis of mRNA transcripts of isolated genes attached to the 5'-proximal translational enhancer sequence;
(iii) selected genes or cDNAs that have been spliced downstream from the translational enhancer sequence can be excised together with the enhancer and this chimeric construct can easily be inserted into vectors that contain eukaryotic transcription signals in order to obtain high-level gene expression in transgenic plants or animals; and
(iv) the α3-seguence can be used as a specific tag for monitoring the transcription level of newly introduced genes in the cases when the transgenic cells are constructed to amplify authentic host genes.
The present invention provides an improved method for the enhanced expression of selected gene products, wherein selected nucleic acids are ligated to the PVX mRNA aβ enhancer fragments or to fragments thereof having enhancer function, forming constructs which may be either translated in vitro in cell-free systems, or used to produce transgenic cells, animals and plants that express the gene product.
The present invention also provides a phagemid (pXK3α,9) , constructed by inserting the aβ sequence derived from PVX mRNA into the phagemid pTZ18R (Pharmacia) , that can be maintained in Escherichia coli as a double-stranded plasmid, or isolated as single- stranded phage, or used to selectively synthesize RNA transcripts for hybridization probes, in vitro translation, protoplast electroporation and cell micro- injection. This pXK3α/3 is a versatile cloning and expression vector that allows nucleic acid sequences such as genes or cDNAs that are inserted downstream from the α,9-leader to be sequenced and/or mutated, or excised as a cassette that contains the αβ sequence together with the gene or cDNA in preparation for microinjection, and/or inserted into plant- and animal-specific vectors. This invention further provides additional phagemids derived from the PXK3α,*3. One of them (pKX3 ) contains the a region of the aβ seguence, the other one (pKX3,9) the β region. It also provides a variety of subfragments derived from the aβ sequence that possess enhancer functions.
This invention also provides a method and a product for producing transgenic cells and transgenic plants.
BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1. (Published) Nucleotide Sequences of the aβ sequence.
Fig. 2. (Published) Cell-free translation of the neomycin phosphotransferase I (NPTI) gene ligated to the PVX aβ seguence (α,9-NPTI) or to the tobacco mosaic virus Ω enhancer (Ω-NPTI) in different protein synthesizing systems: rabbit reticulocyte lysate (RRL) , wheat germ lysate (WG) or Krebs-2 ascite lysate (KA) .
A. Translation in RRL: α/3-NPTI: 10 μg/ l, 20 μ/ml, 40 μ/ml (lanes
1, 2, 3);
Ω-NPTI: 10 μg/ml, 20 μg/ml, 40 μg/ml
(lanes 4, 5, 6) ;
No enhancer-NPT-1: 40 μg/ml (lane 7) ; no
RNA added (lane 8) .
B. Translation in KA:
Ω-NPTI: 40 μg/ml, 20 μg/ml (lanes 1, 2) ; No enhancer-NPTI: 40 Ωg/ml (lane 3); α3-NPTI: 40 μg/ml, 20 μg/ml (lanes 4, 5).
C. Translation in WG:
No enhancer-NPT-1: 80 μg/ml, 120 μg/ml (lanes 1, 2): α3-NPT-l: 80 μg/ml, 120 μg/ml (lanes 3,4); no RNA added (lane 5) 8
Fig. 3. (Published) Nucleotide sequences of the 5'- untranslated leaders of NPT II gene transcripts. Fig. 4. (Published) SDS-PAGE of [35S]-labelled translation products (rabbit reticulocyte lysate) of synthetic RNA transcripts of NPT II gene. Lane 1, control NPT II transcript; lane 3, aβ-containing transcript; lane 3, no RNA added. Concentration of transcripts was 20 μg/ml. Fig. 5. (Published) Nucleotide seguences of the 5'- untranslated leaders of Bacillus thuringiensis toxic protein gene transcripts. Fig. 6. (Published) SDS-PAGE of [35S]-labelled translation products (rabbit reticulocyte lysate) of synthetic RNA transcripts of B. thuringiensis insect control protein gene. Lanes 1 and 2, control transcript (20 and 40 μg/ml, respectively); lanes 3 and 4, αβ- containing transcripts (20 and 40 μg/ml, respectively) . Fig. 7. (Published) Nucleotide sequences of the 5'- untranslated leaders of GUS gene transcripts. Fig. 8. Published) SDS-PAGE of [35S]-labelled translation products (rabbit reticulocyte lysate) of synthetic RNA transcripts of GUS gene. Lanes 1 and 2, control transcript (46 nt leader) (20 and 40 μg/ml, respectively) . Lanes 3 and 4, control transcript (12 nt leader) (20 and 40 μg/ml, respectively) . Lanes 5 and 6, αβ-containing transcript (20 and 40 μg/ml, respectively. Fig. 9. The DNA sequences of the polylinker regions of pXK3α and pXK3J phagemids (A) and nucleotide sequences of the leader regions of the corresponding in vitro RNA transcripts. Fig. 10. Autoradiogram of an 8-20% gradient polyacrylamide-SDS gel containing [35S]-labelled translation products (rabbit reticulocyte lysate) directed by an uncapped RNA transcript of pTMV-CP (lane 1), pXK3α/ϊTMVCP (lane 2), PXK39TMVCP (lane 3), pXK3αTMVCP (lane 4). The concentration of transcripts was 40 ug/ml. The positions of endogenous product (E) and TMV coat protein (CP) are indicated.
Fig. 11. Schematic map of phagemid pXK3Q./3. The numbers correspond to the parental plasmid pTZ18R.
Fig. 12. Nucleotide sequence of the region of pXK3α3 that contains the T7 promoter, the α3-leader and the polylinker.
Fig. 13. a.) Schematic maps of RNA transcripts wherein different subfragments of the aβ region were spliced to the NPT1 gene. b.) Efficiency of translation of the RNA transcripts in 13.b.
DETAILED DESCRIPTION OF THE INVENTION
We have reported the complete nucleotide seguence of PVX genomic RNA (Skryabin et al . (1988) Nucleic Acids Res. 16, 10929-10930). The 5' leader of potato virus X (PVX) genomic RNA (the 83 nucleotide sequence adjacent to the cap structure) has been shown to consist of two distinct sub-sequences, the α-sequence (41 nucleotides 3' to the cap that lack G) and the β-sequence (42 nucleotides upstream from the first AUG) . (Fig. 1, from Smirnyagina et al . (1991) Biochimie 73: 587-598) Computer-based folding predictions suggest that the 5'- proximal region of the αβ sequence is unstructured. In addition, the αβ sequence contains segments that are apparently complementary to the 3'-terminal region of 18S rRNA. Recombinant DNA technigues well known to those skilled in the art were used throughout the studies. These techniques include cloning and production of single strand phagemid DNA (Vieira J. and Messing J. (1987) Methods Enzymol. 154, 3-11) , transformation (Mandel M. and Higa A. (1970) J. Mol. Biol. 53, 154-160), seguencing (Sanger F. et al . (1977) Proc Nat. Acad. Sci. USA 74, 5463-5467) , screening, agarose gel electrophoresis (Dretzen G. et al . (1981) Anal. Biochem. 12, 295-302), polyacrylamide gel electrophoresis (Maxam A.M. and Gilbert W. (1980) Methods Enzymol. 65, 499-503), restriction enzyme mapping (Smith H. 0. and Bernstiel M. L., (1976) Nucl. Acids Res. 3, 2387-2394), modification of DNA fragments (Norrander J. et al . (1983) Gene 26, 101-107), preparation of plasmid DNA (Birnboim H.C. (1984) Methods Enzymol. 100, 243-250) , Southern blotting (Southern E.M. (1975) J. Mol. Biol. 98, 503-520) and filter hybridization (Grunstein M. and Wallace J. (1980) Methods Enzymol. 154, 3-11).
The αβ sequence enhanced the expression of several reporter genes that were inserted 3' to the αβ seguence and translated in cell free systems.
The αβ sequence enhanced the translation of a neomycin phosphotransferase I (NPT1) gene in cell-free systems from rabbit reticulocytes (RRL) , wheat germ (WG) and Krebs-2 ascites cell extracts (KA) by 6 to 40-fold (Fig. 2, taken from Smirnyagina et al . , (1991) Biochimie 73: 587-598). The PVX αβ sequence was about as effective as the TMV Ω sequence in enhancing the expression of a reporter gene. (Fig. 2) However, although the TMV sequence is slightly more efficient, it cannot be used for constructing phagemids similar to the PVX-based pXK3α,9 because the lac Z sequence of the resulting construct contains termination codons in all three reading frames. In a competitive translation experiment (data not shown) , PVX mRNA strongly inhibited TMV mRNA and some other plant virus mRNAs in RRL and WG systems. This competitive ability did not correlate with the presence of the aβ seguence in the competing mRNA. The evidence suggests that the aβ seguence together with about 150 nucleotides of the coding seguence is responsible for the translation competitive ability of PVX RNA.
Enhancement was also observed when the aβ was attached to three other reporter genes: neomycin phosphotransferase II (NPTII, Figs. 3 and 4) Bacillus thuringiensis insect central protein (Figs. 5 and 6) and 3-glucuronidase (GUS, Figs. 7 and 8) . These experiments tested the properties of different chimeric constructs and the influence of gene coding sequences and the non- viral spacer sequences located between aβ sequence and AUG-initiator on the translational enhancement.
For the experiments with the neomycin phosphotransferase type II (NPT II) gene, the Bglll- and BamHl-cut restriction fragment was excised from the pNEO plasmid (Pharmacia-LNB) and spliced into the BamHl cloning site of a phagemid which is also a subject of this invention, pXK3α,5, whose construction is described below. The 5' leader of the transcript of the resulting plasmid includes a relatively long spacer (38 nucleotides in length) located between the AUG initiation codon and the 5'-terminal aβ sequence (Fig. 3) . In the control construct the reporter gene was inserted into the same sites of the pTZlδR polylinker. The plasmids were transcribed without m7GpppG, and the resulting transcripts were translated in the rabbit reticulocyte lysate.
The expression of the NPT II gene was found to be enhanced several fold (Fig. 4) . These results demonstrate that a high level enhancement in the translation of a foreign gene can occur irrespective of the length of a spacer upstream from the initiation codon.
DNA fragments containing Bacillus thuringiensis coleopteran-specific toxic protein gene (Fig. 5) (Dobrzhanskaya et al . , unpublished data) and β- glucuronidase (GUS) gene (Fig. 7) were fused into BamHl- and Hindlll-cut pXK3α,9. The translation in rabbit reticulocyte lysates of both reporter genes was considerably enhanced when the αβ seguence was present (Figs. 6 and 8) .
The α sub-region by itself can enhance the translation of reporter genes to a level comparable with that achieved using the αβ seguence (Figs. 9 and 10) . A DNA fragment that contained the entire α sequence and 8 base pairs of the β sequence (residues 1-50 of the PVX genome) was excised from pXK3α3 by co-digestion with EcoRI and Muni. The fragment was purified by gel electrophoresis and then fused to an EcoRI-cut pTZ18R. The blue colonies that were obtained after transformation of E. coli strain XL-IB were screened by hybridization and sequence analysis. The DNA sequence corresponding to α-sequence and the polylinker in resulting PXK3α phagemid are presented in Fig. 9A. The large DNA fragment isolated during electrophoretic separation of the fragments of an EcoRI-Muni-cut pXK3α/3 was purified, religated and used to transform XL-IB culture. The DNA sequence of the resulting plasmid pXK33 was verified by sequencing (Fig. 9A) .
To measure the enhancer properties of isolated α- and β- sequences, a tobacco mosaic coat protein (TMV-CP)- reporter gene was inserted into the Pst I site of pTX18R (control), pXK3α,5, pXK3α and pXK3/3. The sequences of the 5' leaders of the corresponding RNA transcripts are shown in Fig. 9B.
The expression of the TMV-CP gene in rabbit reticulocyte lysates was found to be enhanced significantly by the aβ seguence as well as by the α sequence alone. No enhancement was observed when the TMV-CP was coupled to the β seguence (Fig. 10) .
Example
We have produced a versatile phagemid expression vector (pXK3α3, Figs. 11 and 12) that allows selected nucleic acid fragments to be inserted downstream from the aβ sequence, sequenced, transcribed in vitro or in vivo, mutated at will and/or excised as a cassette (together with the aβ seguence) for insertion into plant- and animal-specific vectors.
The phagemid was constructed as follows: A double- stranded DNA corresponding to the aβ sequence was chemically synthesized and fused to an EcoRI- and S al- cut pTZ18R phagemid (Pharmacia-LKB) . The resulting pXK3α/3 contained the aβ sequence flanked by an EcoRI site at its 5' border and multiple cloning sites at its 3' border (Figs. 11 and 12) . It also retained all the properties of the parental vector: pKX3α3 can be maintained in E. coli as double-stranded plasmid, or it can be isolated as single-stranded phage following infection of XL-IB or NM522 cultures with the M13K07 helper phage (Pharmacia-LKB) . The phagemid also contains the viral T7 promoter (Fig. 12) which can be used to selectively synthesize RNA transcripts for hybridization probes. Finally, pK 3aβ can be used for in vitro translation, protoplast electroporation and cell micro- injection. Foreign genes or cDNAs can easily be inserted into any of the cloning sites, and the desired chimeric constructs can easily be cloned, isolated and maintained in Escherichia coli strains XL-IB (Stratagene) or NM522 (Pharmacia-LKB) . The Escherichia coli clones that contain an insert can easily be identified by exploiting the fact that the multiple cloning sites are located within the lac Z gene of the pXK3α/3 phagemid. The successful insertion of a selected gene or cDNA will disrupt the lac Z gene. Escherichia coli clones that contain the unmodified pXK3α? can be distinguished from those that contained a modified phagemid by the blue color which the former give on appropriate X-gal indicator plates. This property facilitates cloning by using blue/white screening of recombinants.
Finally, the αβ sequence is also efficient as a translational enhancer in vivo (in protoplasts) and can be used for super-production of proteins in transgenic plants and probably in yeast cells and transgenic animals.
Example
In addition to the αβ sequence itself, several subfragments derived from therefrom are capable of enhancing translation in cell free systems. The deletion of a segment located in the middle of the α region actually enhanced expression (Figure 13) . Furthermore, the insertion of four bases into the β seguence resulted in a sharp six-fold decrease in the enhancement properties of the αβ sequence (Figure 13) . Thus, it seem that long term structural interactions between the different elements of the αβ sequence may play a role in its ability to enhance translation in cell free systems. Example
Modifications and variations of the methods and constructs used throughout this disclosure will be obvious to those skilled in the art from the foregoing detailed description of the invention. Such modifications and variations are intended to come within the scope of the appended claims.
SEQUENCE LISTING
(1) GENERAL INFORMATION:
(i) APPLICANT: Atabekov, Joseph G. Morozov, S. Yu.
(ii) TITLE OF INVENTION: A Method for Overexpressing Nucleic Acids in Cell Free Systems, Cells and Plants Using a Multifunctional Phagemid that Contains an Enhancer Sequence Derived from Potato Virus X
(iii) NUMBER OF SEQUENCES: 15 (iv) CORRESPONDENCE ADDRESS:
(A) ADDRESSEE: Patrick J. Birde
(B) STREET: One Broadway (C) CITY: New York
(D) STATE: NY
(E) COUNTRY: USA
(F) ZIP: 10004
(v) COMPUTER READABLE FORM: (A) MEDIUM TYPE: Floppy disk
(B) COMPUTER: IBM PC compatible
(C) OPERATING SYSTEM: PC-DOS/MS-DOS
(D) SOFTWARE: Patentin Release #1.0, Version
#1.25 (vi) CURRENT APPLICATION DATA:
(A) APPLICATION NUMBER:
(B) FILING DATE: May 8, 1992
(C) CLASSIFICATION: (viii) ATTORNEY/AGENT INFORMATION: (A) NAME: Birde, Patrick J
(C) REFERENCE/DOCKET NUMBER: 1036-24 (ix) TELECOMMUNICATION INFORMATION:
(A) TELEPHONE: (212) 425-7200
(B) TELEFAX: (212) 425-5288
(C) TELEX: 422141 (2) INFORMATION FOR SEQ ID NO:l:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 83 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single (D) TOPOLOGY: linear
(ii) MOLECULE TYPE: RNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (vi) ORIGINAL SOURCE: (A) ORGANISM: Potato Virus X
(viii) POSITION IN GENOME:
(B) MAP POSITION: 1-83
(C) UNITS: bp
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:l: GAAAACUAAA CCAUACACCA CAACACAACC AAACCCACCA CGCCCAAUUG UUACACACCC 60 GCUUGGAAAA GCAAGUCUAA CAA
83 (2) INFORMATION FOR SEQ ID NO:2: (i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 59 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear (ii) MOLECULE TYPE: mRNA
(iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: YES (vi) ORIGINAL SOURCE: (A) ORGANISM: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:2: GGGAAUUCGA GCUCGGUACC CGGGGAUCUG AUCAAGAGAC AGGAUGAGGA UCGUUUCGC 59 (2) INFORMATION FOR SEQ ID NO:3:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 123 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single (D) TOPOLOGY: linear
(ii) MOLECULE TYPE: mRNA (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (vi) ORIGINAL SOURCE: (A) ORGANISM: Potato Virus X
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:3: GGGAAUUCGA AAACUAAACC AUACACCAAC AACACAACCA AACCCACCAC GCCCAAUUGU 60
UACACACCCG CUUGGAAAAG UAAGUCUAAC GGGGAUCAAG AGACAGGAUG AGGAUCGUUU 120 CGC
123 (2) INFORMATION FOR SEQ ID NO: :
(i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 42 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear (ii) MOLECULE TYPE: mRNA (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:4: GGGAAUUCGA GCUCGGUACC CGGGGAUCCG GGAGGAAGAA AA 42 (2) INFORMATION FOR SEQ ID NO:5:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 124 base pairs (B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear (ii) MOLECULE TYPE: mRNA
(iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO
(vi) ORIGINAL SOURCE:
(A) ORGANISM: Bacillus thuringiensis (xi) SEQUENCE DESCRIPTION: SEQ ID NO:5: GGGAAUUCGA AAACUAAACC AUACACCAAC AACACAACCA AACCCACCAC GCCCAAUUGU 60
UACACACCCG CUUGGAAAAG UAAGUCUAAC GAGCUCGGUA CCCGGGGAUC
CGGGAGGAAG 120
AAAA
124 (2) INFORMATION FOR SEQ ID NO:6:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 46 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single (D) TOPOLOGY: linear
(ii) MOLECULE TYPE: mRNA (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:6: GGGCGAAUUC GAGCUCGGUA CCGGAUCCCC GGGUGGUCAG UCCCUU
46 (2) INFORMATION FOR SEQ ID NO:7:
(i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 12 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear (ii) MOLECULE TYPE: mRNA
(iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:7: GGGAAUUCUA CC 12
(2) INFORMATION FOR SEQ ID NO:8:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 97 base pairs
(B) TYPE: nucleic acid (C) STRANDEDNESS: single
(D) TOPOLOGY: linear (ii) MOLECULE TYPE: mRNA (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:8:
GGGAAUUCGA AAACUAAACC AUACACCAAC AACACAACCA AACCCACCAC GCCCAAUUGU 60
UACACACCCG CUUGGAAAAG UAAGUCUAAC GGGAUCC 97 (2) INFORMATION FOR SEQ ID NO:9:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 107 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single (D) TOPOLOGY: linear
(ii) MOLECULE TYPE: CDNA to mRNA (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:9: AATTCGAAAA CTAAACCATA CACCAACAAC ACAACCAAAC CCACCACGCC CAATTCGAGC 60
TCGGTACCCG GGGATCCTCT AGAGTCGACC TGCAGGCATG CAAGCTT 107
(2) INFORMATION FOR SEQ ID NO:10: (i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 74 base pairs
(B) TYPE: nucleic acid (C) STRANDEDNESS: single
(D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA to mRNA (iii) HYPOTHETICAL: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:10: AATTGTTACA CACCCGCTTG GAAAAGTAAG TCTAACGGGG ATCCTCTAGA GTCGACCTGC 60 AGGCATGCAA GCTT
74 (2) INFORMATION FOR SEQ ID NO:11: (i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 67 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear (ii) MOLECULE TYPE: mRNA
(iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:11: GGGAAUUCGA GCUCGGUACC CGGGGAUCCU CUAGAGUCGA CCUGCAGGUC GAGGAUUCGU 60 AUUAAAU
67 2) INFORMATION FOR SEQ ID NO:12: (i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 136 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single (D) TOPOLOGY: linear
(ii) MOLECULE TYPE: mRNA (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (vi) ORIGINAL SOURCE: (A) ORGANISM: tabacco mosaic virus
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:12: GGGAAUUCGA AAACUAAACC AUACACCAAC AACACAACCA AACCCACCAC GCCCAAUUGU 60
UACACACCCG CUUGGAAAAG UAAGUCUAAC GGGGAUCCUC UAGAGUCGAC CUGCAGGUCG 120 AGGAUUCGUA UUAAAU
136 (2) INFORMATION FOR SEQ ID NO:13: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 118 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear (ii) MOLECULE TYPE: mRNA (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:13: GGGAAUUCGA AAACUAAACC AUACACCAAC AACACAACCA AACCCACCAC GCCCAAUUCG 60 AGCUCGGUAC CCGGGGAUCC UCUAGAGUCG ACCUGCAGGU CGAGGAUUCG UAUUAAAU 118 (2) INFORMATION FOR SEQ ID NO:14: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 81 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear (ii) MOLECULE TYPE: mRNA
(iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:14: AAUUGUUACA CACCCGCUUG GAAAAGUAAG UCUAAGGGGA UCCUCUAGAG UCGACCUGCA 60
GGUCGAGGAU UCGUAUUAAA U
81 (2) INFORMATION FOR SEQ ID NO:15: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 144 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear (ii) MOLECULE TYPE: mRNA * (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (vi) ORIGINAL SOURCE:
(A) ORGANISM: Potato Virus X (xi) SEQUENCE DESCRIPTION: SEQ ID NO:15: TAATACGACT CACTATAGGG AATTCGAAAA CTAAACCATA CACCACAACA CAACCAAACC 60
CACCACGCCC AATTGTTACA CACCCGCTTG GAAAAGCAAG TCTAACGGGG ATCCTCTAGA 120 GTCGACCTGC AGGCATGCAA GCTT 144

Claims

2-1 CLAIMS
We claim:
1) A vector for cloning purified nucleic acid fragments and expressing them in cells, plants and cell- free systems, comprising a subfragment of a Potato Virus X aβ enhancer seguence having enhancer function, covalently linked to an isolated purified nucleic acid not of Potato Virus origin.
2) A vector according to claim 2 that is a member of the group that includes plasmids, phagemids, and phages.
3) A vector according to claim 2 in which the isolated purified nucleic acid not of Potato Virus X origin is covalently linked 3' to the subfragment of the aβ enhancer sequence.
4) A phagemid according to claim 2 wherein said phagemid further comprises a nucleic acid sequence derived from a pTZlδR phagemid.
5) A phagemid according to claim 2 wherein said phagemid is selected from the group that includes the phagemids pXK3α3, pXK3α, and pXK3/3.
6) A cell that comprises the isolated, purified nucleic acid sequence covalently linked to the aβ subfragment according to claim 1.
7) The cell of claim 6 in which the isolated, purified nucleic acid fragment is covalently linked 3' to the subfragment of the aβ sequence.
8) The cell of claim 7 in which the isolated, purified nucleic acid sequence covalently linked to a subfragment of the aβ sequence is incorporated into the cell's genome.
9) A plant comprising a cell according to claim 7.
10) A plant comprising a cell according to claim 8.
11) A seed comprising a cell according to claim 7.
12) A seed comprising a cell according to claim 8.
13) A vector according to claim 2 having inserted therein a nucleic acid sequence having substantially the same sequence and substantially the same enhancing activity as the PVX a sequence.
14) A vector according to claim 13 having inserted therein a subfragment of the PVX a sequence having substantially the same enhancing activity as the PVX a sequence.
15) A vector according to claim 2 having inserted therein a nucleic acid sequence having substantially the same sequence and substantially the same enhancing activity as the PVX β sequence.
16) A vector according to claim 15 having inserted therein a subfragment of the PVX β sequence having substantially the same enhancing activity as the PVX β sequence.
17) In a method causing expression of a recombinant nucleic acid, said system being capable of a predetermined rate of polypeptide expression, an improvement comprising covalently linking said recombinant nucleic acid 3' to a subfragment of a Potato Virus X aβ enhancer seguence having enhancer function.
18) A method according to claim 17 in which the constructs are introduced into cells via the group of techniques that includes infection, transfection, transformation, microinjection, electroporation, and calcium precipitation.
19) A method for cloning and expressing purified isolated nucleic acid sequences in cell free systems, cells or plants, comprising: a) a member of a group of plasmids, phagemids and phages that includes the phagemids pXK3a3, pXK3α and pXK3/3; b) having inserted therein a nucleic acid fragment covalently linked to a nucleic acid fragment that contains a region having substantially the same sequence and substantially the same expression- enhancing effect as the group of sequences that includes the Potato Virus X aβ sequence and the a sequence; c) further comprising cloning any of the group of constructs described in 19.b. into a suitable bacterium; d) further comprising sequencing the constructs to confirm that they are indeed the constructs described in 19.b. ; e) further comprising amplifying and purifying the constructs; f) further comprising introducing the construct into cells; g) further comprising using probes that are complementary to any part of the aβ sequence as a specific tag for monitoring the transcription level of newly introduced genes.
20) A vector for cloning purified nucleic acid fragments and expressing them in cells, plants and cell- free systems, comprising a Potato Virus X aβ enhancer sequence having enhancer function, covalently linked to an isolated purified nucleic acid not of Potato Virus origin.
PCT/US1992/005403 1991-06-27 1992-06-26 A method for over-expressing nucleic acids using an enhancer sequence from potato virus x WO1993003138A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SU4950052 RU2005788C1 (en) 1991-06-27 1991-06-27 Rna-fragment of potato x-virus intended for foreign gene translation
RU4950052/13 1991-07-27

Publications (1)

Publication Number Publication Date
WO1993003138A1 true WO1993003138A1 (en) 1993-02-18

Family

ID=21581674

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1992/005403 WO1993003138A1 (en) 1991-06-27 1992-06-26 A method for over-expressing nucleic acids using an enhancer sequence from potato virus x

Country Status (3)

Country Link
AU (1) AU2305592A (en)
RU (1) RU2005788C1 (en)
WO (1) WO1993003138A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002081647A2 (en) * 2001-04-06 2002-10-17 The Scripps Research Institute Bioluminescent plants and methods of making same

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BIOCHIMIE, Volume 72, No. 9, issued September 1990, S.Y. MOROZOV et al., "Expression of RNA Transcripts of Potato Virus X Full-Lenght and Subgenomic cDNAs", pages 677-684. *
BIOCHIMIE, Volume 73, No. 5, issued May 1991, E.V. SMIRNYAGINA et al., "Translational Efficiency and Competitive Ability of mRNAs with 5'-Untranslated Alpha Beta-Leader of Potato Virus X RNA", pages 587-598. *
CHEMICAL ABSTRACTS, Volume 114, No. 5, issued February 1991, E.V. SMIRNYAGINA et al., "5'-Untranslated Leader of the Potato Virus X Genomic RNA as Highly Efficient Translational Enhancer", page 166, abstract no. 36777v; & DOKL. AKAD. NAUK. SSSR, 314(4), 979-980. *
FEBS LETTERS, Volume 296, No. 3, issued January 1992, D.A. ZELENINA et al., "Translational Enhancing Properites of the 5'-Leader of Potato Virus X Genomic RNA", pages 267-270. *
NUCLEIC ACIDS RESEARCH, Volume 15, No. 21, issued 1987, D.R. GALLIE et al., "A Comparison of Eukaryotic Viral 5'-Leader Sequences as Enhancers of mRNA Expression In Vivo", pages 8693-8711. *
NUCLEIC ACIDS RESEARCH, Volume 16, No. 10, issued 1988, S.A. JOBLING et al., "In Vitro Transcription and Translational Efficiency of Chimeric SP6 Messenger RNAs Devoid of 5' Vector Nucleotides", pages 4483-4498. *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002081647A2 (en) * 2001-04-06 2002-10-17 The Scripps Research Institute Bioluminescent plants and methods of making same
WO2002081647A3 (en) * 2001-04-06 2003-09-04 Scripps Research Inst Bioluminescent plants and methods of making same

Also Published As

Publication number Publication date
AU2305592A (en) 1993-03-02
RU2005788C1 (en) 1994-01-15

Similar Documents

Publication Publication Date Title
JP2645217B2 (en) Chimeric genes expressed in plant cells
US5034322A (en) Chimeric genes suitable for expression in plant cells
Li et al. Expression of a bifunctional green fluorescent protein (GFP) fusion marker under the control of three constitutive promoters and enhanced derivatives in transgenic grape (Vitis vinifera)
RU2148647C1 (en) Method of expression of interesting dna sequence in seed cell, dna-structure, expression cassette, isolated regulatory site of transcription and method of alternation of specific metabolism in seeds
US5641876A (en) Rice actin gene and promoter
AU721571B2 (en) The promoter (FLt) for the full-length transcript of peanut chlorotic streak caulimovirus (PC1SV)
CA2006454C (en) Potatoe tuber specific transcriptional regulation
US6174724B1 (en) Chimeric genes suitable for expression in plant cells
EP0571741A2 (en) An expression plasmid for seeds
US5527674A (en) Genetic construct for selection of homologous recombinants on a single selective medium
WO1998005198A9 (en) THE PROMOTER (FLt) FOR THE FULL-LENGTH TRANSCRIPT OF PEANUT CHLOROTIC STREAK CAULIMOVIRUS (PC1SV)
Fobert et al. Detection of gene regulatory signals in plants revealed by T-DNA-mediated fusions
WO1992014819A1 (en) A positive selection vector for the bacteriophage p1 cloning system
Goldsbrough et al. Expression of maize zein genes in transformed sunflower cells
JPS61502166A (en) Improved methods and vectors for transformation of plant cells
EP0494724A2 (en) Plasmids for controlling expression in plants
WO1991009948A1 (en) Rice actin gene and promoter
JPH08505523A (en) RNA packaging system
US5442052A (en) Expression of genes in transgenic plants
Luehrsen et al. Insertion of Mu1 elements in the first intron of the Adh1-S gene of maize results in novel RNA processing events.
Choisne et al. Transactivation of a target gene using a suppressor tRNA in transgenic tobacco plants
WO1993003138A1 (en) A method for over-expressing nucleic acids using an enhancer sequence from potato virus x
JP4627879B2 (en) 5'-untranslated region sequence having high gene expression ability in plant cells
Franklin et al. Construction and expression of nonsense suppressor tRNAs which function in plant cells
US6664384B1 (en) Duplicated cassava vein mosaic virus enhancers and uses thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AT AU BB BG BR CA CH CS DE DK ES FI GB HU JP KP KR LK LU MG MN MW NL NO PL RO RU SD SE

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU MC NL SE BF BJ CF CG CI CM GA GN ML MR SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
EX32 Extension under rule 32 effected after completion of technical preparation for international publication

Ref country code: UA

LE32 Later election for international application filed prior to expiration of 19th month from priority date or according to rule 32.2 (b)

Ref country code: UA

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA